v3.25.2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balances at Dec. 31, 2022 $ 0 $ 422,982 $ (1,316) $ (405,727) $ 15,939
Balance, shares at Dec. 31, 2022 573,282 2,617        
Issue of common stock, preferred stock and associated warrants on underwritten offering, net of expenses 1,049 1,049
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Registered Direct Offering, net of expenses, shares   735        
Series B Preferred stock conversions
Series B Preferred stock conversions, shares (118,745) 165        
Reclassification of redeemable common stock 4,494 4,494
Reclassification of redeemable common stock, shares   866        
Stock-based compensation 1,473 1,473
Stock-based compensation, shares   29        
Preferred stock dividends (201) (201)
Unrealized foreign exchange on intercompany loans 12,550 12,550
Translation adjustment (12,142) (12,142)
Loss for the period (22,555) (22,555)
Balances at Dec. 31, 2023 $ 0 429,797 (908) (428,282) 607
Balance, shares at Dec. 31, 2023 454,537 4,412        
Series B Preferred stock conversions
Series B Preferred stock conversions, shares (119,000) 165        
Stock-based compensation 203 203
Unrealized foreign exchange on intercompany loans (2,130) (2,130)
Translation adjustment 2,140 2,140
Loss for the period (2,946) (2,946)
Issue costs on issuance of common stock upon conversion of pre-funded warrants in underwritten offering (80) (80)
Issue costs on issuance of common stock upon conversion of pre-funded warrants in underwritten offering, shares   915        
Balances at Mar. 31, 2024 $ 0 429,920 (898) (431,228) (2,206)
Balance, shares at Mar. 31, 2024 335,537 5,493        
Balances at Dec. 31, 2023 $ 0 429,797 (908) (428,282) 607
Balance, shares at Dec. 31, 2023 454,537 4,412        
Issue of common stock, preferred stock and associated warrants on underwritten offering, net of expenses $ 0 6,209 6,209
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Registered Direct Offering, net of expenses, shares   2,944        
Series B Preferred stock conversions
Series B Preferred stock conversions, shares (119,000) 165        
Stock-based compensation 592 592
Unrealized foreign exchange on intercompany loans (2,899) (2,899)
Translation adjustment 2,916 2,916
Loss for the period (11,212) (11,212)
Conversion of series 6% Convertible Exchangeable Preferred
Conversion of series 6% Convertible Exchangeable Preferred, shares (200,000) 0        
Warrant Exercises $ 0 1,613 1,613
Warrant Exercises, shares   29,391        
Issue costs on issuance of common stock upon conversion of pre-funded warrants in underwritten offering   $ 72,108       6,290,213
Balances at Dec. 31, 2024 $ 0 438,211 (891) (439,494) (2,174)
Balance, shares at Dec. 31, 2024 135,537 36,913        
Stock-based compensation 1,666 1,666
Unrealized foreign exchange on intercompany loans (2,380) (2,380)
Translation adjustment           3,272
Loss for the period (81) (81)
Issue costs on issuance of common stock upon conversion of pre-funded warrants in underwritten offering   72,108       6,290,213
Issue costs on issuance of common stock, preferred stock and associated warrants on underwritten offering, net of expenses (248) (248)
Issue of Series C preferred stock in Securities Purchase Agreement $ 1 999 1,000
Issue of Series C preferred stock in Securities Purchase Agreement, shares 1,000,000          
Series C Preferred stock conversions $ (1) $ 0 (1)
Series C Preferred stock conversions, shares (1,000,000) 11,042        
Issue of Series D preferred stock in Securities Purchase Agreement $ 2 1,892 1,894
Issue of Series D preferred stock in Securities Purchase Agreement, shares 2,100,000          
Series D Preferred stock conversions $ (2) $ 1 (1)
Series D Preferred stock conversions, shares (1,745,262) 799,912        
Issue of Series D preferred stock in Securities Purchase Agreement $ 1 999 1,000
Issue of Series D preferred stock in Securities Purchase Agreement, shares 1,000,000          
Warrant Exercise
Warrant Exercise, shares   15,277        
Issue of common stock on Securities Purchase Agreement
Issue of common stock on Securities Purchase Agreement, shares   758        
Deconsolidation of Subsidiary 886 (886)
Translation adjustment 2,385 2,385
Balances at Mar. 31, 2025 $ 1 $ 1 $ 443,521 $ (440,461) $ 3,062
Balance, shares at Mar. 31, 2025 1,490,275 863,902